DataPile investor atlas

Angel investors & venture capitalists in Indiana, United States

Last updated 25-10-2025. Data refreshed weekly.

6 Matches for your filters
16 Total investors in region
3,050 Profiles tracked nationwide
16 Based in Indiana
Indianapolis (6) Largest investor hub
Eli Lilly and Company, Samtec Inc Notable firms

Refine investor results

Toggle multiple filters to narrow the directory instantly.

Location

States & regions

Cities

Industry focus

We found 6 investors based in Indianapolis.

Market intelligence

  • Most active investment themes in Indiana, United States: venture capital & private equity, electrical, electronic manufacturing.
  • 6 profiles are headquartered in Indianapolis, making it the busiest hub in Indiana, United States.
  • Featured firms include Eli Lilly and Company, Samtec Inc, Miles Ahead, American Water.

Explore states in United States

Showing 1 – 6 of 6 investors

Holly Pearsall profile photo Monument MicroCap Partners, LLC logo
Holly Pearsall
Vice President of Marketing and Investor Relations
Monument MicroCap Partners, LLC
Focus areas
venture capital & private equity coinvestment corporate acquisition acquisitions microcap strategic acquisitions investing private equity selling a business how to sell your business private equity investment investment firm microcap private equity firm top private equity firms mergers buyouts institutional investor leveraged buyouts management buyouts small company buyouts lower middle market venture capital & private equity principals operational improvements niche manufacturing add-on acquisitions other financial investment activities ebitda $2-8 million technology and engineering content business acquisition b2b manufacturing portfolio management supply chain management organic revenue growth distribution regenerative medicine business services value creation market sector expertise risk management industry expertise distribution and supply chain business growth debt repayment market research services management partnership microcap market technology operational efficiency finance financial services mechanical or industrial engineering logistics & supply chain
Location
Indianapolis, Indiana, United States
Signals
Katie Kopan profile photo High Alpha logo
Katie Kopan
Associate
High Alpha
Focus areas
venture capital & private equity saas software cloud enterprise software b2b information technology venture capital & private equity principals venture capital b2b saas co-creation startup acceleration funding innovation healthcare software sales enablement supply chain solutions agtech customer engagement minimum viable product founder partnership portfolio companies market entry digital transformation operational support strategic guidance community impact technology solutions early-stage startups corporate innovation saas ecosystem business growth entrepreneurial support market feedback product-market fit venture studio model industry expertise scalable solutions customer advocacy employee scheduling automated bookkeeping conversational intelligence hybrid events management learning management systems audio advertising workplace culture assessments startup incubation founder partnerships capital investment software development scaling solutions ai integration go-to-market strategy market analysis cloud-based applications risk management compliance solutions design resources marketing automation learning management e-commerce solutions data analytics customer relationship management lead generation sales management growth acceleration performance optimization financial forecasting human resources management portfolio management event management community engagement digital marketing remote work solutions personalized marketing performance metrics subscription pricing investment strategy mobile applications customer insights team collaboration tools social media marketing content marketing connected platforms operational efficiency workflow automation data protection supply chain optimization consulting services computer software information technology & services enterprises marketing & advertising consumer internet consumers internet crm sales events services mobile apps
Location
Indianapolis, Indiana, United States
Signals
Marc Kemen profile photo Eli Lilly and Company logo
Marc Kemen
Senior Director - Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals
Mike Sprengnether profile photo Eli Lilly and Company logo
Mike Sprengnether
Senior Director, Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals
Susan Hedglin profile photo Eli Lilly and Company logo
Susan Hedglin
Senior Director, Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals
Tyler Foxworthy profile photo JMI Equity logo
Tyler Foxworthy
Data Scientist | Investor | Private Equity Advisor
JMI Equity
Focus areas
venture capital & private equity venture capital & private equity principals growth equity software investments capital investment strategic guidance operational support high-growth companies recurring revenue proven business models intellectual property value creation b2b software cloud solutions human capital management customer relationship management identity management project management advertising technology healthcare it financial planning software regulatory compliance digital transformation emerging growth companies diversity and inclusion portfolio companies market expansion risk management shareholder value industry leaders technology investments customer satisfaction innovation operational expertise team-building support software companies capital investments strategic advice team-building operational excellence human resources market segmentation customer success high performance culture investment management business management data analytics financial services quality management technology firms customer engagement enterprise solutions performance management fundraising software telehealth digital accessibility financial aid solutions employee benefits sales enablement marketing automation go-to-market strategy performance benchmarking lead generation customer retention business processes compliance software service automation field service management contract lifecycle management emergency communications cybersecurity solutions supply chain management customer experience management education technology b2b consulting services cloud computing enterprise software enterprises computer software information technology & services crm sales privacy productivity marketing & advertising saas logistics & supply chain e-learning internet education management
Location
Indianapolis, Indiana, United States
Signals

Explore other regions in United States